Last reviewed · How we verify
Phentermine and B12 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Phentermine and B12 (Phentermine and B12) — Dr. Michael Lang.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Phentermine and B12 TARGET | Phentermine and B12 | Dr. Michael Lang | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Phentermine and B12 CI watch — RSS
- Phentermine and B12 CI watch — Atom
- Phentermine and B12 CI watch — JSON
- Phentermine and B12 alone — RSS
Cite this brief
Drug Landscape (2026). Phentermine and B12 — Competitive Intelligence Brief. https://druglandscape.com/ci/phentermine-and-b12. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab